INCR Market Analysis
News & Sentiment
43 articles · sorted by datePage 1 of 3 · 43 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio—Forward 6.18
EPS (TTM)$-0.95-84.7% YoY
Profit margin-13.2%HEALTHCARE
Market cap$59.6MMicro cap
Valuation
- Forward P/E
- 6.18
- PEG ratio
- —
- P/B
- 0.47
- P/S (TTM)
- 0.50
- EV/EBITDA
- 5.29
Profitability & growth
- ROE (TTM)
- -9.3%
- Operating margin
- 0.0%
- Revenue growth YoY
- 23.9%
- Dividend yield
- —
- Beta
- 0.64
Last earnings
Nov 18, 2025 · Estimate $0.05 · Reported $0.00
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About InterCure Ltd.
Company profileSyneos Health, Inc., a contract research organization, provides various clinical development services for the medical device and biopharmaceutical industries in North America, Europe, the Middle East and Africa, Asia-Pacific, and Latin America. The company is headquartered in Raleigh, North Carolina.
Classification
- Sector
- Healthcare
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 85 MEDINAT HA-YEHUDIM STREET, HERZLIYA, ISRAEL
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$59.6M
Shares outstanding$15.0M
52W high$7.55
52W low$3.40
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent